https://health-union.com/wp-content/uploads/2021/04/HU-linkedin-blog-mobie-042021.jpg
628
1200
Felicia Brecher
https://health-union.com/wp-content/uploads/2025/01/hu-higher-res-logo-2.png
Felicia Brecher2021-04-26 11:02:492021-05-04 12:54:273 Considerations for Pharma Brand Strategy SuccessHealth Union’s data-driven industry conversations help pharma make smarter, more effective decisions.
Check out our latest thought leadership pieces below.
https://health-union.com/wp-content/uploads/2021/04/HU-linkedin-blog-mobie-042021.jpg
628
1200
Felicia Brecher
https://health-union.com/wp-content/uploads/2025/01/hu-higher-res-logo-2.png
Felicia Brecher2021-04-26 11:02:492021-05-04 12:54:273 Considerations for Pharma Brand Strategy Success
Mitigating the Misdiagnosis Journey

Continuity of Care in a Pandemic: Reflecting on the Rise of Telehealth

Addressing Gaps As Telehealth Use Grows, Satisfaction Varies
Maximizing Consumer Engagement with People Living with Rare Disease
Understanding the difficulties people with rare conditions often face can help set the table for the engagement challenges pharma marketers typically face.
Introducing the 2023 Social Health Awards Winners
Meet the groundbreaking group of 2023 award winners who you can connect with through Health Union’s Social Health Network!
What Is HCP Targeting?
With advanced HCP targeting, you can focus your ad spend on a more cultivated target list of HCPs.
Rare Conditions: The Impact of Mental Health Concerns
More than half of NMOSD In America 2022 respondents said being diagnosed with NMOSD has negatively impacted their mental health.
Contact
1218 Chestnut St., 3rd Floor
Philadelphia, PA 19107
Phone: 484-985-9715
Fax: 484-450-2513
![]()
Privacy Notice
Terms of Use
Your Privacy Choices ![]()
Privacy Rights Request Form
Join Our Team
Press Kit




